W9 Adverse Drug Reactions (AG) Flashcards

1
Q

What is the Definition of Chemotherapy?

A
  • A treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemotherapy may be given by mouth, injection, or infusion, or on the skin, depending on the type and stage of the cancer being treated. It may be given alone or with other treatments, such as surgery, radiation therapy, or biologic therapy.”

Chemotherapy are high risk drugs!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of A Cytotoxic Agent?

A

A substance that kills cells, including cancer cells. These agents may stop cancer cells from dividing and growing and may cause tumours to shrink in size.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of Ca treatments available? (7)

A

Hormone therapy
Surgery
Bone marrow transplantation
Chemotherapy
Targeted therapy
Radiation therapy
Immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the Aim of chemotherapy?

A

To do maximum damage to cancer cells whilst causing minimum damage to healthy tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adverse events with of Chemotherapy?

A

Mouth ulcers, nausea/vomiting
nephrotoxicity, diarrhoea, cystitis, infertility, neurotoxicity, hair loss, lung toxicity, cardiotoxocity, local reaction, skin changes, bone marrow suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common side effects And Actions to take to treat this?

A
  • Neutropenia – delay chemo/ give G-CSF* / dose reduction
  • Thrombocytopenia – delay chemo / dose reduction
  • Mucositis – depends on severity- gelclair/ raspberry mucilage/caphasol (artificial saliva)
  • Diarrhoea – loperamide, codeine
  • Alopecia – cold cap/ wigs
  • Nausea & vomiting – metoclopramide, ondansetron, aprepitant
  • Skin toxicity
  • Neuropathy
  • Fatigue

*E.g. Filigristin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Less common adverse events

A
  • Ototoxicity
  • Hepatic impairment (transient or permanent)
  • Electrolyte disturbances
  • Ocular toxicity
  • Secondary malignancies

Some of these can take months / years to develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute phase reactions
ACUTE adverse events? (4) and drugs that cause this?

A
  1. Anaphylaxis (any drug)
  2. Infusion related / hypersensitivity reactions (carboplatin, paclitaxel)
  3. Extravasation (cisplatin) -leakage of chemo drug outside of a vein
  4. Acute cholinergic syndrome (irinotecan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypersensitivity reactions (Need to know)
What are the symptoms?
Immediate Management steps?

A

*Difficulty breathing
*Noisy breathing
*Swollen tongue, lips and face
*Swelling or tightness in the throat
*Difficulty talking or a hoarse voice
*Wheezing and coughing *Tummy pain and vomiting
*Dizziness
*Collapse

Immediate Management:
- Stop chemotherapy infusion
- Administer hydrocortisone 100mg IV and chlorphenamine 10mg IV
- Obs inc pulse, bp, sats
- ECG and/or cardiac monitor for severe reactions
- Close monitoring and repeat obs until symptoms resolve

Can be a delayed reaction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Extravasation
What is it?
What are the risk factors?

A
  • Unintentional leakage of fluid from vein into surrounding tissue during administration
  • Rare (<5%)

Risk factors:
* Site of venipuncture (blood draw)
(size of vein, fragility, radiotherapy)
* Diabetes / vascular disorders
* Size/ age
* Number of previous administrations
* Vesicant drugs (doxorubicin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Extravasation: what to do? (7)

A

1.Stopping the flow of chemotherapy drugs through the IV.
2.As much as possible, removing the spilled drugs from the affected area.
3.Removing the IV.
4.Elevating the affected arm.
5.Applying cream to ease symptoms.
6.Applying cold compresses. Cold compresses help with pain.
7.Applying warm compresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute Cholinergic Syndrome- Irinotecan:
Symptoms?
Treatment?

A
  • Diarrhoea (can be life threatening!)
  • Sweating
  • Salivation
  • Bradycardia
  • May start during irinotecan infusion or shortly afterwards
  • Inhibition of acetylcholinesterase
  • Treatment atropine sulphate S/C (anti-cholinergic)
  • Prophylaxis with atropine given with all cycles
    .
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

BLOOD & Chemotherapy
Bone Marrow Toxicity:

A
  • Red blood cells & white blood cells are constantly produced in bone marrow
  • They grow rapidly – susceptible to toxic effects of chemotherapy

Life span
▪ RBC 120 days
▪ Neutrophils 6 hours
▪ Platelets 10 days
* Different chemotherapy drugs will produce a “NADIR” (lowest blood counts) at different times post chemo – average 7 – 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptoms of bone marrow toxicity:
for RBC, WBC, Platelets?

A

Red Blood Cells:
- breathlessness
- feeling tired
- dizziness

Platelets:
- bruising easily
- bleeding taking a long time to stop
- blood in urine or faeces

White Blood Cells:
- reduced ability to fight infection
- increased risk of sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neutropenia & chemotherapy:
Neutropenic sepsis (NS)
What is the neutrophil range to diagnose a patient with NS?
What 2 other symptoms to confirm a diagnosis?

A
  • Diagnose NS in patients having anticancer treatment whose neutrophil count is 0.5 × 10^9 (normal >1.5) neutrophils per litre or lower and who have either:
  • A temperature higher than 38°C OR
  • other signs or symptoms consistent with clinically significant sepsis.
  • Sepsis is a syndrome defined as life-threatening organ dysfunction due to a
    dysregulated host response to infection.
    =ACUTE MEDICAL EMERGENCY!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Febrile Neutropenia? (FN)
Possible complications?
Treatment to prevent this?

A
  • FN is the most common complication of anticancer treatment, and describes the presence of fever in a person with neutropenia.
  • Possible complications of NS include organ failure, invasive and atypical infection, coagulopathy, encephalopathy and delirium, psychological sequelae and death.
  • FN can be effectively prevented by the use of G-CSFs (filgrastim)
    =ACUTE MEDICAL EMERGENCY!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Febrile Neutropenia (FN) – risk factors?
(need to know)

A
  • Older age
  • Advanced disease/metastasis
  • No abx prophylaxis
  • Prior episode of FN
  • No use of G-CSFs
  • Female
  • Asian race
  • Anemia (Hb <12 g/dL)
  • CVD
  • Renal disease
  • Abormal liver transaminases
  • ECOG score >2
  • Patient with comorbidity ( >1)
  • Baseline ANC ( <1500 cells/mm3)
  • Baseline serum albumin <3.5g/dL
  • Poor nutritional status and/or lower weight
  • Prior chemo or radiotherapy
  • Prior infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How to prevent neutropenia?

A
  • Use of GCSF (filgrastim)
  • S/C admin
  • Expensive
  • Admin >24 hours post chemo
  • Continue until after NADIR
  • Continue until neutrophils recovered
  • Stop >24 hours before chemo
  • G-CSF ADRs: Hypersensitivity, interstitial lung disease, capillary leak syndrome,
    glomerulonephritis, splenomegaly, splenic rupture, malignant cell growth, thrombocytopenia, leucocytosis, immunogenicity etc. – Bone pain!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chemotherapy alert card:

A

Given to patients- especially so hospital can identify this they are experiencing and ADR such as Febrile neutropenia (FN) OR Neutropenic Sepsis (NS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What do you do if: “Neutrophils fall and fail to recover to adequate level before the next cycle of chemotherapy?

A
  • Do they have FN?
  • Treatment delay until recovery
  • Dose reduction (relationship between the severity of neutropenia which
    directly influences the incidence of FN and the intensity of Chemo)
  • Use of GCSF (filgrastim)
  • What you do depends on intent and implications of dose reduction
  • Neutropenic sepsis – ONCOLOGICAL/ MEDICAL EMERGENCY – Urgent/immediate antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anaemia and Chemotherapy:
Anaemia (low RBCs)
Symptoms?

A
  • Reduction in number of RBC
  • Easily corrected – blood transfusion – not always cause treatment delay
  • Think iron/ B12 /folate – ensure replaced if needed
  • Possible to use erythropoietin
  • Significant impact on quality of life
  • More common with platinum-based chemo (cisplatin, carboplatin, oxaliplatin)
  • Symptoms:
    ▪ Fatigue, Weakness, Shortness of breath, Heaviness in legs, Decreased stamina,
    Inability to concentrate
22
Q

Thrombocytopenia & chemotherapy
Thrombocytopenia (low platelets)

Most common with which drugs? (2)

A
  • Platelet transfusion (only when exceptionally low)
  • TREATMENT DELAY OR DOSE REDUCTION
    Educate patients to report:
    ▪ Unexplained bruising
    ▪ Bleeding gums
    ▪ Nose bleeds
    ▪ Most common with gemcitabine and platinum-based chemotherapy
    (cisplatin)
23
Q

Diarrhoea & chemotherapy
What do you need to know about the patient?

A
  • Defined as loose or watery bowel movements as well as a significant increases in the frequency of bowel movements
  • Chemotherapy can cause inflammation of or damage to cells of the gut lining.
  • Chemo can also destroy or damage enzymes that digest food

CRUCIAL: **Need to know treatment received **as management very different for chemotherapy or immunotherapy induced diarrhoea or targeted therapy

24
Q

Chemotherapy induced diarrhoea:
Caused by which drugs? (2)
Treatment?

A

Potential life-threatening complication:
* Capecitabine/ 5-fluorouracil
* Irinotecan (see earlier slide acute cholinergic syndrome)

Treatment with:
* Loperamide
* Atropine with irinotecan (acute cholinergic reaction)
* Hydration (oral or IV)
* Electrolyte replacement
* Prophylactic antibiotics

  • May need hospital admission, dose reduction for future cycles
25
Q

Tips for coping with diarrhoea for patient?

A
  • Drink plenty of liquid (at least 2 litres or 3½ pints a day) to replace the fluid lost with the diarrhoea.
  • Avoid drinking alcohol and coffee.
  • Eat small, frequent meals made from light foods, for example white fish, poultry, well-cooked eggs, white bread, pasta or rice.
  • Eat your meals slowly.
  • Eat less fibre (for example cereals, raw fruits and vegetables) until the diarrhoea improves.
  • Avoid greasy, fatty foods such as chips and beef burgers, and spicy foods like chilli peppers.
26
Q

Alopecia (hair loss)
Management?
Drugs that cause this?

A
  • Distressing
  • May prevent treatment or alter choice of treatment
  • Usually occurs within 2-3 weeks of starting

Management:
▪ Re-assurance
▪ Scalp cooling
▪ Hats/ scarfs , wigs

  • Drugs cyclophosphamide, anthracyclines, etoposide, paclitaxel
27
Q

Scalp cooling: What is it?

A

Prevention
* Reduces blood flow to hair
follicles during treatment
* Only effective with drugs with
short half-life (epirubicin)
* Different cap size
* Lengthens appointment time

28
Q

Skin toxicity & Nail damage
1. Palmer-Plantar Erythem:
Caused by?
What occurs?
Treatment?

  1. Rash
  2. Nail damage
A
  • Capecitabine
  • Painful skin cracking and fissures
    mainly soles of feet
  • and palms of hands
  • Emollients
  • Pyridoxine tablets (vit B6)
  1. Rash
    * First line emollients or topical steroids
    * Antibiotics
    * Systemic steroids
  2. Nail damage
    * Docetaxel
29
Q

Drugs used in chemotherapy induced N&V?

A
  • NK1 antagonists:
    Aprepitant
  • 5HT3 antagonists:
    Ondansetron
  • D2 antagonists:
    Metoclopramide, domperidone
  • Glucocorticoids:
    Dexamethasone
  • M1 antagonists
    Hyoscine hydrobromide
  • Antipyschotics:
    Olanzapine, droperidol, haloperidol,
    levomepromazine, prochlorperazine
  • H1 antagonists:
    Cyclizine (&M1)
30
Q

Chemotherapy induced - Nausea & Vomiting
Different types? (5)

A

Acute, Delayed, Breakthrough, Refractory, Anticipatory

acute- occurs within 24hrs
delayed- 24hrs post and peaks 48-72hrs
breakthrough- occurs within 5 days
refractory- occurs in subsequent chemo cycles
anticipatory- triggered by sensory stumuli assoc with chemo eg entering a hospital, anxiety

31
Q

Management N&V - ACUTE

A
  • Prevention is better than cure
  • Choice of anti-emetics is dependent on emetogenic potential of the chemotherapy drug.
  • In regimes, choice based on the most emetogenic drugs to be administered
  • ALWAYS commence anti-emetics before chemotherapy
  • Give oral anti-emetics at least 30minutes before chemotherapy
  • Anti-emetic best given regularly in acute phase
  • Effective management essential to minimise potential delay, anticipatory or hospital admissions
32
Q

Management N&V - DELAYED

A
  • Prevention key
  • Difficult to manage
  • Not always responsive to standard anti-emetics
  • Corticosteroids in combination standard anti-emetics (eg dexamethasone)
33
Q

Management N&V – ANTICIPATORY

A
  • Learnt response or anxiety related
  • Occurs in up 20% of patients by cycle 4 of chemo
  • Prevent by effective control of ACUTE and DELAYED phase from 1st cycle
  • Unlikely to ever get anticipatory N&V if patient does NOT
    develop N&V
  • Benzodiazepines may help - lorazepam
34
Q

Mucositis

A
  • Most likely with methotrexate, high dose
    cyclophosphamide
  • No universally agreed best treatment
  • Encourage good oral hygiene
  • Extremely debilitating and effects nutritional intake
  • May require nutritional support / dietician
  • If severe, treatment delay and / or dose reduction
  • Extreme cases hospital admission – syringe drivers for pain
35
Q

Give mouth washes with local analgesics, coating agents or anti-inflammatories

A

examples in slide
gelclair gel, mucilage, sucralfate, muguard
difflam, saltwater mouthwash corsodyl,
many more..

also for systemic pain relief, analgesia can be given in order of WHO ladder

36
Q

Neuropathy- 3 types?

A
  • Peripheral neuropathy
    Loss of tendon reflexes
    Paraesthesia
    Motor weakness
    Foot drop
    caused by Cisplatin Vincristine
  • Autonomic neuropathy
    Constipation
    Ileus
    caused by any
  • Central neuropathy
    Cranial nerve palsy (ototoxicity)
    Cerebellar Ataxia
    Encephalopathy
    Seizures
    caused by Ifosfamide
    Vincristine
    Cisplatin
    Methotrexate
37
Q

Fatigue
management?

A
  • Universally experienced by all
  • Often presents as sleeping difficulties &
    reduced concentration
  • Debilitating
  • Encourage coping strategies (physical activity, good diet, sleep, relaxation, complementary treatments,
    emotional support)
  • Information from charities
  • Ensure not anaemia / thyroid - test to rule this out
38
Q

Renal toxicity can lead to..

A
  • Renal tubular damage (can be permanent)
  • Cisplatin, methotrexate
  • Electrolyte loss
  • Hypomagnesaemia – cetuximab, cisplatin
  • Proteinuria
39
Q

How to Reduce incidence of nephrotoxicity?

A
  • Hydration to maintain adequate urine output
  • Electrolyte replacement (K+, Mg2+)
  • Forces diuresis (IV mannitol or furosemide)
  • Mesna – see haemorrhagic cystitis
  • Alkalinisation of urine
  • IV sodium bicarbonate
  • pH monitoring
  • Facilitates excretion of methotrexate
40
Q

Haemorrhagic cystitis

A
  • Dose dependent cyclophosphamide &
    ifosfamide
  • MESNA used to bind the toxic metabolite acrolein.
  • Acrolein binders are used to prevent damage to the lining of the bladder.
41
Q

Hepatotoxicity (liver toxicity)

A

Raised ALT /AST
* Gemcitabine, methotrexate, anthracyclines
* May require dose reductions

42
Q

Cardiotoxicity

A
  • Irreversible cardiac damage with some drugs - Anthracycline (doxorubicin)
  • Maximum cumulative doses must be adhered to as risk of cardiac damage
    increases with increased exposure to the drug (doxorubicin life-time dose 450-550
    mg/m2)
    Trastuzumab (& related drugs):
  • Baseline ejection fraction and monitored periodically – drop in EF use ACE
    inhibition
    Coronary artery spasm/ MI – caution in cardiac history – Capecitabine & 5-
    fluorouracil
43
Q

Cancer Associated Thrombosis

A
  • Deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • ↑morbidity & ↑mortality
44
Q

Tumour Lysis Syndrome

A
  • Oncological emergency
  • Occurs when malignant cells rapidly break down, releasing their contents into the bloodstream
  • Causes significant changes to the levels of electrolytes within the blood
  • Occurs after the initiation of chemotherapy (12-72 hours)

Leads to:
* Hyperuricaemia
* Hyperphosphataemia
* Hypocalcaemia (secondary to hyperphosphataemia)
* Hyperkalaemia

45
Q

Tumour Lysis Syndrome - Management

A

General management:
* Intravenous fluids: maintain urine output >100 mL/m²/hour (monitor urine output hourly)
* Observations should be monitored at least 4-6 hourly, including fluid balance assessment
* Daily weights
* Blood tests every 6 hours
* ECG at baseline, consider cardiac monitor if hyperkalaemia/hypocalcaemia

Management of electrolyte abnormalities includes:
* Hyperuricaemia: intravenous rasburicase for 3-7 days (use maximum dose allopurinol if rasburicase contraindicated)
* Hyperkalaemia: calcium gluconate for cardiac protection, followed by a glucose/insulin infusion
* Hyperphosphataemia: phosphate-binding agents can be considered but are rarely used
* Hypocalcaemia: symptomatic hypocalcaemia should be treated with IV calcium gluconate;
* Seizures can be managed with anticonvulsant medication according to local guidelines

46
Q

Fertility problems

A
  • Pre-treatment counselling
  • Men – offer sperm bank
  • Ovarian tissue preservation
  • Some women will experience amenorrhoea – may be reversible
  • Advise barrier method of contraception during treatment and a period afterwards
47
Q

Folinic acid

A
  • Folinic acid (given as calcium folinate) is used to counteract the folate-antagonist action of methotrexate and thus speed
    recovery from methotrexate-induced mucositis or myelosuppression (folinic acid rescue).
  • Folinic acid is also used in the management of methotrexate overdose, together with other measures to maintain fluid and
    electrolyte balance, and to manage possible renal failure.
48
Q

Known Adverse Drug Reactions of Methotrexate and Vincristine:
A) Bone marrow suppression
B) Neurotoxicity
C) Hepatotoxicity
D) Renal toxicity
E) Mucositis
F) Peripheral neuropathy
G) Pulmonary fibrosis
H) Haemorrhagic cystitis

  1. A 55-year-old patient receiving methotrexate therapy for cancer presents with symptoms for which he was given folinic acid.
  2. A 60-year-old patient on vincristine for non-Hodgkin lymphoma reports paraesthesia and foot drop
A
  1. E
  2. F
49
Q

Management of Adverse Drug Reactions
Options:
A) Mesna
B) Gabapentin
C) Pyridoxine (Vitamin B6)
D) Methotrexate dose reduction
E) Folic acid
F) Topical lidocaine
G) Opioids
H) Phenytoin

  1. A patient receiving cyclophosphamide reports painful urination with blood in the urine.
    o Answer:
  2. A patient experiencing severe neuropathic pain due to cisplatin is unable to tolerate standard pain relief.
    o Answer:
A
  1. A
  2. B
50
Q

Mr. SQ was recently started on the chemotherapy agent doxorubicin and has experienced hypersensitivity reactions.
a) Describe five potential symptoms of hypersensitivity reactions related to doxorubicin. (5 marks)
b) Outline five key steps in the management of hypersensitivity reactions to doxorubicin. (5 marks)

A

a) Difficulty breathing
b) Noisy breathing
c) Swollen tongue, lips and face
d) Swelling or tightness in the throat
e) Difficulty talking or a hoarse voice
f) Wheezing and coughing
g) Tummy pain and vomiting
h) Dizziness
i) Collapse

b) Stop chemotherapy infusion
Administer hydrocortisone 100mg and chlorphenamine 10mg IV
Take Obs= Pulse, BP, O2
ECG and/or cardiac monitor for severe reactions